Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
654
datasets available to search
ShareScore release 0.9.0
Dataset results
654 results for “estrogen receptor”
A Study of Apatinib Combined With Letrozole With or Without Fluzoparib in Estrogen Receptor-Positive, Platinum-Sensitive Recurrent Ovarian Cancer Previously Treated With First-Line PARP Inhibitor
ClinicalTrials.gov study NCT07000344. IPD Sharing: NO. Countries: 0. Publications: 0.
Evaluation of the Unconformity of the Hormonal Status of Metastatic Lesions During a First Relapse of Breast Cancer Initially Expressing Estrogen Receptors: a Pilot Study on the Interest of PET With F
ClinicalTrials.gov study NCT03873428. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy
ClinicalTrials.gov study NCT02483871. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial
ClinicalTrials.gov study NCT07191717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients
ClinicalTrials.gov study NCT02132000. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women
ClinicalTrials.gov study NCT03418831. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer
ClinicalTrials.gov study NCT00084396. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy
ClinicalTrials.gov study NCT02414776. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
ClinicalTrials.gov study NCT02476786. IPD Sharing: NO. Countries: 1. Publications: 0.
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT06260033. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED)
ClinicalTrials.gov study NCT00799708. IPD Sharing: Not stated. Countries: 0. Publications: 0.
BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer
ClinicalTrials.gov study NCT01339442. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT03573648. IPD Sharing: NO. Countries: 1. Publications: 0.
Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
ClinicalTrials.gov study NCT03709082. IPD Sharing: NO. Countries: 1. Publications: 0.
Activated Glucocorticoid Receptor is an Estrogen Receptor Silencer in ERα+ metastatic breast cancer [RNA-seq]
GEO Series GSE286890. Homo sapiens. 24 samples. Type: Expression profiling by high throughput sequencing.
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [ATAC-seq]
GEO Series GSE109890. Homo sapiens. 4 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer
GEO Series GSE123770. Homo sapiens. 144 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing.
Estrogen Receptor alpha ChIP-Seq in mouse mammary gland
GEO Series GSE43415. Mus musculus. 2 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Genome-Wide Maps of WT and DBDmut Estrogen Receptor in Human Breast Cancer Cells
GEO Series GSE22609. Homo sapiens. 2 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Pharmacologic activation of G protein-coupled estrogen receptor inhibits pancreatic ductal adenocarcinoma
GEO Series GSE117312. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.